PHIO

#4756
Phio Pharmaceuticals Corp. Common Stock
1.2900 USD
+4.03%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
1.2900
1.2900
년간 변동
0.9780
1.3500
일일 변동
+4.03%
월간 변동
+6.61%
6달 변화
+8.40%
년간 변동율
+8.40%
이전 종가
1.2400
Open
1.2900
Bid
Ask
Low
1.2900
High
1.2900
양
3
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

뉴스